Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3454)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,437
Price
$568.33
Total Value
$816.69K
Shares Held After
41,870
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,280
Price
$567.45
Total Value
$1.29M
Shares Held After
43,307
% of Holdings
5.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,117
Price
$566.33
Total Value
$1.20M
Shares Held After
45,587
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,811
Price
$565.34
Total Value
$1.02M
Shares Held After
47,704
% of Holdings
3.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
365
Price
$564.11
Total Value
$205.90K
Shares Held After
49,515
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
133
Price
$563.01
Total Value
$74.88K
Shares Held After
49,880
% of Holdings
0.3%
KalVista Pharmaceuticals, Inc. (KALV)
Yea Christopher — CHIEF DEVELOPMENT OFFICER
Shares
1,108
Price
$26.76
Total Value
$29.65K
Shares Held After
227,367
% of Holdings
0.5%
Seres Therapeutics, Inc. (MCRB)
Brady Kelly — Chief Operating Officer, EVP
Shares
59
Price
$7.53
Total Value
$444.27
Shares Held After
8,562
% of Holdings
0.7%
Seres Therapeutics, Inc. (MCRB)
Henn Matthew R — Chief Scientific Officer and EVP
Shares
77
Price
$7.53
Total Value
$579.81
Shares Held After
7,838
% of Holdings
1.0%
Seres Therapeutics, Inc. (MCRB)
Shaff Eric D. — Director
Shares
259
Price
$7.53
Total Value
$1.95K
Shares Held After
12,040
% of Holdings
2.1%
Seres Therapeutics, Inc. (MCRB)
DesRosier Thomas — EVP and Chief Legal Officer
Shares
79
Price
$7.53
Total Value
$594.87
Shares Held After
7,954
% of Holdings
1.0%
KalVista Pharmaceuticals, Inc. (KALV)
Audhya Paul K. — CHIEF MEDICAL OFFICER
Shares
1,032
Price
$26.76
Total Value
$27.62K
Shares Held After
143,934
% of Holdings
0.7%
KalVista Pharmaceuticals, Inc. (KALV)
Palleiko Benjamin L — Director
Shares
1,129
Price
$26.76
Total Value
$30.21K
Shares Held After
467,665
% of Holdings
0.2%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
198
Price
$28.15
Total Value
$5.57K
Shares Held After
1,394,094
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
118,037
Price
$27.19
Total Value
$3.21M
Shares Held After
1,394,292
% of Holdings
7.8%
Zenas BioPharma, Inc. (ZBIO)
MOULDER LEON O JR — Director
Shares
60,000
Price
$16.88
Total Value
$1.01M
Shares Held After
96,928
% of Holdings
61.9%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
5,700
Price
$0.92
Total Value
$5.24K
Shares Held After
291,566
% of Holdings
2.0%
Ultragenyx Pharmaceutical Inc. (RARE)
SULIMAN SHEHNAAZ — Director
Shares
5,740
Price
$25.12
Total Value
$144.19K
Shares Held After
27,951
% of Holdings
17.0%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
700
Price
$61.16
Total Value
$42.81K
Shares Held After
16,406
% of Holdings
4.1%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
800
Price
$60.34
Total Value
$48.27K
Shares Held After
17,106
% of Holdings
4.5%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
4,600
Price
$59.19
Total Value
$272.26K
Shares Held After
17,906
% of Holdings
20.4%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
4,190
Price
$58.34
Total Value
$244.47K
Shares Held After
22,506
% of Holdings
15.7%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Soergel David — Chief Medical Officer
Shares
844
Price
$515.90
Total Value
$435.42K
Shares Held After
11,075
% of Holdings
7.1%
Showing 401–450 of 3454 transactions (page 9 of 70)